Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Grésenguet G[au]:

A brief review on features of falciparum malaria during pregnancy. Manirakiza A et al. J Public Health Afr. (2017)

Spectrum of female commercial sex work in Bangui, Central African Republic. Longo JD et al. SAHARA J. (2017)

Insufficient education is a challenge for HIV self-testing. Tonen-Wolyec S et al. Lancet HIV. (2018)

Search results

Items: 1 to 50 of 88

1.

Infrequent detection of human papillomavirus infection in head and neck cancers in the Central African Republic: a retrospective study.

Kofi B, Mossoro-Kpinde CD, Mboumba Bouassa RS, Péré H, Robin L, Gresenguet G, Bélec L.

Infect Agent Cancer. 2019 Apr 8;14:9. doi: 10.1186/s13027-019-0225-x. eCollection 2019.

2.

High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.

Mboumba Bouassa RS, Mossoro-Kpinde CD, Gody JC, Veyer D, Péré H, Matta M, Robin L, Grésenguet G, Charpentier C, Bélec L.

J Antimicrob Chemother. 2019 Jul 1;74(7):2030-2038. doi: 10.1093/jac/dkz099.

3.

Persistent high-risk behavior and escalating HIV, syphilis and hepatitis B incidences among men who have sex with men living in Bangui, Central African Republic.

Marcel MS, De Dieu LJ, Magloire CS, Grésenguet G, Ralph-Sydney MB, Piette D, Gulbis B, Bélec L.

Pan Afr Med J. 2018 Feb 23;29:132. doi: 10.11604/pamj.2018.29.132.12794. eCollection 2018.

4.

Insufficient education is a challenge for HIV self-testing.

Tonen-Wolyec S, Mboup S, Grésenguet G, Bouassa RB, Bélec L.

Lancet HIV. 2018 Jul;5(7):e341. doi: 10.1016/S2352-3018(18)30141-3. No abstract available.

PMID:
30052505
5.

Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic.

Mboumba Bouassa RS, Mbeko Simaleko M, Camengo SP, Mossoro-Kpinde CD, Veyer D, Matta M, Robin L, Longo JD, Grésenguet G, Péré H, Meye JF, Belec L.

PLoS One. 2018 May 24;13(5):e0197845. doi: 10.1371/journal.pone.0197845. eCollection 2018.

6.

Usefulness of simultaneous screening for HIV-specific and HCV-specific antibodies and HBsAg by a capillary-based multiplex rapid diagnostic test to strengthen linkage-to-care in sub-Saharan patients attending sexually transmitted infection clinic.

Longo JD, Mboumba Bouassa RS, Mbeko Simaleko M, Kouabosso A, Mossoro-Kpinde CD, Robin L, Charmant L, Grésenguet G, Bélec L.

J Med Virol. 2018 Sep;90(9):1549-1552. doi: 10.1002/jmv.25209. Epub 2018 May 25.

PMID:
29718536
7.

A brief review on features of falciparum malaria during pregnancy.

Manirakiza A, Serdouma E, Ngbalé RN, Moussa S, Gondjé S, Degana RM, Bata GGB, Moyen JM, Delmont J, Grésenguet G, Sepou A.

J Public Health Afr. 2017 Dec 31;8(2):668. doi: 10.4081/jphia.2017.668. eCollection 2017 Dec 31.

8.

Task-shifting of CD4 T cell count monitoring by the touchscreen-based Muse™ Auto CD4/CD4% single-platform system for CD4 T cell numeration: Implication for decentralization in resource-constrained settings.

Kouabosso A, Mossoro-Kpinde CD, Bouassa RM, Longo JD, Mbeko Simaleko M, Grésenguet G, Bélec L.

J Immunol Methods. 2018 Apr;455:95-98. doi: 10.1016/j.jim.2018.01.008. Epub 2018 Feb 2.

PMID:
29402397
9.

Acceptability and Usability Evaluation of Finger-Stick Whole Blood HIV Self-Test as An HIV Screening Tool Adapted to The General Public in The Central African Republic.

Grésenguet G, Longo JD, Tonen-Wolyec S, Mboumba Bouassa RS, Belec L.

Open AIDS J. 2017 Nov 21;11:101-118. doi: 10.2174/1874613601711010101. eCollection 2017.

10.

Risk factors for HIV infection among female sex workers in Bangui, Central African Republic.

Longo JD, Simaleko MM, Diemer HS, Grésenguet G, Brücker G, Belec L.

PLoS One. 2017 Nov 6;12(11):e0187654. doi: 10.1371/journal.pone.0187654. eCollection 2017.

11.

Spectrum of female commercial sex work in Bangui, Central African Republic.

Longo JD, Simaléko MM, Ngbale R, Grésenguet G, Brücker G, Bélec L.

SAHARA J. 2017 Dec;14(1):171-184. doi: 10.1080/17290376.2017.1394907.

12.

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study.

Mossoro-Kpinde CD, Gody JC, Mboumba Bouassa RS, Mbitikon O, Jenabian MA, Robin L, Matta M, Zeitouni K, Longo JD, Costiniuk C, Grésenguet G, Touré Kane NC, Bélec L.

Medicine (Baltimore). 2017 Mar;96(10):e6282. doi: 10.1097/MD.0000000000006282.

13.

Analytical Performances of Human Immunodeficiency Virus Type 1 RNA-Based Amplix® Real-Time PCR Platform for HIV-1 RNA Quantification.

Mossoro-Kpinde CD, Mboumba Bouassa RS, Jenabian MA, Wolyec ST, Robin L, Matta M, Longo JD, Grésenguet G, Andreoletti L, Bélec L.

AIDS Res Treat. 2016;2016:7954810. doi: 10.1155/2016/7954810. Epub 2016 Dec 5.

15.

Evaluation of the Upgraded Version 2.0 of the Roche COBAS® AmpliPrep/COBAS® TaqMan HIV-1 Qualitative Assay in Central African Children.

Mossoro-Kpinde CD, Jenabian MA, Gody JC, Robin L, Talla P, Longo J, Grésenguet G, Belec L.

Open AIDS J. 2016 Aug 5;10:158-163. eCollection 2016.

16.

Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.

LeGoff J, Roques P, Jenabian MA, Charpentier C, Brochier C, Bouhlal H, Gresenguet G, Frost E, Pepin J, Mayaud P, Belec L; ANRS12-12 Study Group.

Clin Microbiol Infect. 2015 Sep;21(9):873.e1-9. doi: 10.1016/j.cmi.2015.05.014. Epub 2015 May 21.

17.

[Elimination or control of the onchocerciasis in Africa? Case of Gami village in Central African Republic].

Yaya G, Kobangué L, Kémata B, Gallé D, Grésenguet G.

Bull Soc Pathol Exot. 2014 Aug;107(3):188-93. doi: 10.1007/s13149-014-0363-8. Epub 2014 May 10. French.

PMID:
24816795
18.

[Scabies: epidemiological, clinical and therapeutic features in Bangui].

Kobangué L, Guéréndo P, Abéyé J, Namdito P, Mballa MD, Gresenguet G.

Bull Soc Pathol Exot. 2014 Feb;107(1):10-4. doi: 10.1007/s13149-014-0324-7. Epub 2013 Dec 21. French.

PMID:
24363018
19.

Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding.

Moussa S, Jenabian MA, Gody JC, Léal J, Grésenguet G, Le Faou A, Bélec L.

PLoS One. 2013 May 21;8(5):e63408. doi: 10.1371/journal.pone.0063408. Print 2013.

20.

The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative.

Wiysonge CS, Armah GE, Madhi SA, Were F, Kitaka SB, Akoua-Koffi C, Gresenguet G, Gatheru Z, Maranga PW, Dicko A, Falade AG, Boula AY, Kuit SB, Odusanya OO, Sow PS, Lakhani N, Mpabalwani EM, Tamfum JJ, Hussey GD.

Pan Afr Med J. 2011;8:24. Epub 2011 Mar 14.

21.

Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.

Péré H, Charpentier C, Mbelesso P, Dandy M, Matta M, Moussa S, De Dieu Longo J, Grésenguet G, Abraham B, Bélec L.

AIDS Res Hum Retroviruses. 2012 Apr;28(4):315-23. doi: 10.1089/aid.2011.0127. Epub 2011 Sep 23.

PMID:
21942692
22.

Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.

Weiss HA, Paz Bailey G, Phiri S, Gresenguet G, LeGoff J, Pepin J, Lewis DA, Belec L, Hoffman IF, Miller WC, Mayaud P.

PLoS One. 2011;6(7):e22601. doi: 10.1371/journal.pone.0022601. Epub 2011 Jul 25.

23.

Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.

LeGoff J, Grésenguet G, Gody C, Longo Jde D, Khonde N, Weiss HA, Mayaud P, Bélec L; ANRS 12-12 Study Group.

Clin Vaccine Immunol. 2011 Jul;18(7):1191-3. doi: 10.1128/CVI.05003-11. Epub 2011 May 11.

24.

[Cervical dysplasia in women with human immunodeficiency virus (HIV) in areas of high prevalence of infection].

Koffi B, Serdouma E, Mbolissa-Nguérékoudou W, Ngadjou-Kouchou-Fondjo M, Pengoussou-Gbatoumba V, Sépou A, Grésenguet G.

Gynecol Obstet Fertil. 2010 Oct;38(10):576-80. doi: 10.1016/j.gyobfe.2010.08.031. French.

PMID:
20869289
25.

Policy brief on improving access to artemisinin-based combination therapies for malaria in Central African Republic.

Gresenguet G, Moyen M, Koffi B, Bangamingo JP.

Int J Technol Assess Health Care. 2010 Apr;26(2):242-5. doi: 10.1017/S0266462310000231. No abstract available.

PMID:
20392335
26.

Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.

Mayaud P, Legoff J, Weiss HA, Grésenguet G, Nzambi K, Bouhlal H, Frost E, Pépin J, Malkin JE, Hayes RJ, Mabey DC, Bélec L; ANRS 1212 Study Group.

J Infect Dis. 2009 Jul 15;200(2):216-26. doi: 10.1086/599991.

PMID:
19530940
27.

[Use of spirulina supplement for nutritional management of HIV-infected patients: study in Bangui, Central African Republic].

Yamani E, Kaba-Mebri J, Mouala C, Gresenguet G, Rey JL.

Med Trop (Mars). 2009 Feb;69(1):66-70. French.

PMID:
19499738
28.

High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.

Gody JC, Charpentier C, Mbitikon O, Si-Mohamed A, LeGoff J, Grésenguet G, Bélec L.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):566-9. doi: 10.1097/QAI.0b013e318183acae. No abstract available.

PMID:
19202461
29.

Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.

LeGoff J, Mayaud P, Gresenguet G, Weiss HA, Nzambi K, Frost E, Pepin J, Belec L; ANRS 12-12 Study Group.

J Clin Microbiol. 2008 Jun;46(6):1914-8. doi: 10.1128/JCM.02332-07. Epub 2008 Apr 2.

30.

Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.

Eslahpazir J, Jenabian MA, Bouhlal H, Hocini H, Carbonneil C, Grésenguet G, Mbopi Kéou FX, LeGoff J, Saïdi H, Requena M, Nasreddine N, de Dieu Longo J, Kaveri SV, Bélec L.

Clin Vaccine Immunol. 2008 May;15(5):872-84. doi: 10.1128/CVI.00463-07. Epub 2008 Mar 19.

31.

Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins.

Requena M, Bouhlal H, Nasreddine N, Saidi H, Gody JC, Aubry S, Grésenguet G, Kazatchkine MD, Sekaly RP, Bélec L, Hocini H.

Immunology. 2008 Apr;123(4):508-18. Epub 2007 Nov 10.

32.

Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.

LeGoff J, Weiss HA, Gresenguet G, Nzambi K, Frost E, Hayes RJ, Mabey DC, Malkin JE, Mayaud P, Belec L.

AIDS. 2007 Jul 31;21(12):1569-78.

PMID:
17630552
33.

Genetic and phenotypic features of blood and genital viral populations of clinically asymptomatic and antiretroviral-treatment-naive clade a human immunodeficiency virus type 1-infected women.

Andreoletti L, Skrabal K, Perrin V, Chomont N, Saragosti S, Gresenguet G, Moret H, Jacques J, Longo Jde D, Matta M, Mammano F, Belec L.

J Clin Microbiol. 2007 Jun;45(6):1838-42. Epub 2007 Apr 25.

34.

Early archives of genetically-restricted proviral DNA in the female genital tract after heterosexual transmission of HIV-1.

Chomont N, Hocini H, Grésenguet G, Brochier C, Bouhlal H, Andréoletti L, Becquart P, Charpentier C, de Dieu Longo J, Si-Mohamed A, Kazatchkine MD, Bélec L.

AIDS. 2007 Jan 11;21(2):153-62.

PMID:
17197805
35.

Influence of storage temperature on the stability of HIV-1 RNA and HSV-2 DNA in cervicovaginal secretions collected by vaginal washing.

Legoff J, Tanton C, Lecerf M, Grésenguet G, Nzambi K, Bouhlal H, Weiss H, Belec L; ANRS1212 Study Group.

J Virol Methods. 2006 Dec;138(1-2):196-200. Epub 2006 Aug 21.

PMID:
16919788
36.

Allele frequencies and haplotypes of eight Y-short tandem repeats in Bantu population living in Central Africa.

Lecerf M, Filali M, Grésenguet G, Ndjoyi-Mbiguino A, Le Goff J, de Mazancourt P, Bélec L.

Forensic Sci Int. 2007 Sep 13;171(2-3):212-5. Epub 2006 Jun 12.

PMID:
16769189
37.

Enterovirus RNA shedding in the genital tract of childbearing-aged women living in Central Africa.

Jacques J, Bélec L, Moret H, Grésenguet G, Longo Jde D, Chomont N, Brodard V, Matta M, Graesslin O, Andréoletti L.

J Med Virol. 2006 May;78(5):591-7.

PMID:
16555273
38.

Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.

Legoff J, Bouhlal H, Grésenguet G, Weiss H, Khonde N, Hocini H, Désiré N, Si-Mohamed A, de Dieu Longo J, Chemin C, Frost E, Pépin J, Malkin JE, Mayaud P, Bélec L.

J Clin Microbiol. 2006 Feb;44(2):423-32.

39.

Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women.

Andréoletti L, Chomont N, Grésenguet G, Matta M, de Dieu Longo J, Carreno MP, Si-Mohamed A, Legoff J, Kazatchkine MD, Bélec L.

J Infect Dis. 2003 Aug 15;188(4):549-54. Epub 2003 Jul 29.

PMID:
12898442
40.

Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women.

Mbopi-Kéou FX, Legoff J, Grésenguet G, Si-Mohamed A, Matta M, Mayaud P, Andreoletti L, Malkin JE, Weiss H, Brown D, Bélec L.

J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):121-4. No abstract available.

PMID:
12794542
41.

Immunohematological reference ranges for adults from the Central African Republic.

Menard D, Mandeng MJ, Tothy MB, Kelembho EK, Gresenguet G, Talarmin A.

Clin Diagn Lab Immunol. 2003 May;10(3):443-5.

42.

Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.

Mbopi-Kéou FX, Bélec L, Dalessio J, Legoff J, Grésenguet G, Mayaud P, Brown DW, Morrow RA.

Clin Diagn Lab Immunol. 2003 May;10(3):388-93.

43.
44.

Voluntary HIV counseling and testing: experience among the sexually active population in Bangui, Central African Republic.

Grésenguet G, Séhonou J, Bassirou B, Longo Jde D, Malkin JE, Brogan T, Bélec L.

J Acquir Immune Defic Syndr. 2002 Sep 1;31(1):106-14.

PMID:
12352157
45.

Acceptability of the female condom in Bangui, Central African Republic: results from a prospective study.

Séhonou J, Grésenguet G, Tokunaga M, Mbopi Kéou FX, Favier C, Bélec L.

Int J STD AIDS. 2002 Sep;13(9):649-51. No abstract available.

PMID:
12243136
46.

Vitamin A deficiency and genital tract infections in women living in Central Africa.

Bélec L, Mbopi-Kéou FX, Roubache JF, Mayaud P, Paul JL, Grésenguet G.

J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):203-4. No abstract available.

PMID:
11832693
47.

Detection of Y chromosome DNA as evidence of semen in cervicovaginal secretions of sexually active women.

Chomont N, Grésenguet G, Lévy M, Hocini H, Becquart P, Matta M, Tranchot-Diallo J, Andreoletti L, Carreno MP, Kazatchkine MD, Bélec L.

Clin Diagn Lab Immunol. 2001 Sep;8(5):955-8.

48.

Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid: a prerequisite to assess HIV-specific vaginal immunity and HIV genital shedding.

Chomont N, Grésenguet G, Hocini H, Becquart P, Matta M, Andreoletti L, Si-Mohamed A, Carreno MP, Kazatchkine M, Bélec L.

AIDS. 2001 Apr 13;15(6):801-2. No abstract available.

PMID:
11371697
49.

Aetiology of urethral discharge in Bangui, Central African Republic.

Morency P, Dubois MJ, Grésenguet G, Frost E, Mâsse B, Deslandes S, Somsé P, Samory A, Mberyo-Yaah F, Pépin J.

Sex Transm Infect. 2001 Apr;77(2):125-9.

50.

High frequency of asymptomatic shedding of herpes simplex virus type 2 in African women.

Bélec L, Grésenguet G, Mbopi Kéou FX, Mayaud P.

Clin Microbiol Infect. 2000 Jan;6(1):56-7. No abstract available.

Supplemental Content

Loading ...
Support Center